Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | CFD | P00746 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | GGT1 | P19440 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1317371 | 0.87 | CFD (0.71) | KMT2ACFDALDH1A1RAB9ANPC1 | |
| SCHEMBL30482833 | 0.84 | SRC (0.58) | KMT2AALDH1A1SMN1; SMN2LMNAABCB1 | |
| SCHEMBL1210111 | 0.84 | SRC (0.58) | KMT2AALDH1A1SMN1; SMN2LMNAABCB1 | |
| SCHEMBL12773409 | 0.82 | KMT2A (0.55) | KMT2AALDH1A1LMNAABCB1DDB1 | |
| SCHEMBL8350024 | 0.82 | TSHR (0.60) | CFDALDH1A1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL6301456 | 0.81 | TSHR (0.49) | KMT2ACFDALDH1A1RAB9ANPC1 | |
| SCHEMBL15759757 | 0.81 | KMT2A (0.54) | KMT2AABCB1DDB1CRBNMEN1 | |
| SCHEMBL18928202 | 0.81 | MAPT (0.59) | KMT2ACFDALDH1A1RAB9ANPC1 | |
| SCHEMBL22950969 | 0.81 | KDM4E (0.61) | KMT2ACFDALDH1A1RAB9ANPC1 | |
| SCHEMBL789388 | 0.81 | PTGDR2 (0.63) | CFDALDH1A1RAB9ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070263060-A1 | Hybrid Energy Curable Solvent-Based Liquid Printing Inks | SUN CHEMICAL CORPORATION | 2007-11-15 | — | — | US | claimed |
| WO-2005071027-A1 | HYBRID ENERGY CURABLE SOLVENT-BASED LIQUID PRINTING INKS | SUN CHEMICAL CORPORATION (US) | 2005-08-04 | — | — | WO | claimed |
| US-20020016226-A1 | UV curable coating for golf balls | LORD CORPORATION | 2002-02-07 | — | — | US | claimed |
| WO-2001094452-A2 | UV CURABLE COATING FOR GOLF BALLS | LORD CORPORATION (US) | 2001-12-13 | — | — | WO | claimed |
| WO-1995011927-A1 | POLYESTER-MODIFIED POLYDIENE/ACRYLOURETHANE OLIGOMERS | LORD CORPORATION (US) | 1995-05-04 | — | — | WO | claimed |
| CN-109415353-B | Pegylated carfilzomib compounds | 美国安进公司 | 2023-01-10 | — | — | CN | disclosed |
| EP-3464277-B1 | PEGYLATED CARFILZOMIB COMPOUNDS | AMGEN INC (US) | 2022-12-28 | — | — | EP | disclosed |
| US-11077198-B2 | Pegylated carfilzomib compounds | AMGEN INC. (US) | 2021-08-03 | — | — | US | disclosed |
| US-11077198-B2 | Pegylated carfilzomib compounds | AMGEN INC. (US) | 2021-08-03 | — | — | US | disclosed |
| US-10953626-B2 | Coated articles and methods for making the same | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2021-03-23 | — | — | US | disclosed |
| US-20200376131-A1 | Pegylated Carfilzomib Compounds | AMGEN INC. (US) | 2020-12-03 | — | — | US | disclosed |
| US-20200376131-A1 | Pegylated Carfilzomib Compounds | AMGEN INC. (US) | 2020-12-03 | — | — | US | disclosed |
| US-4198200-A | THERMOSETTING ADDITION-POLYMERIZED UNSATURATED URETHANE OR UREA RESIN, PHOTOFLASH GLASS COATING | LORD CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| US-4119640-A | ACRYLIC OR METHACRYLIC ACID, DIEPOXIDES, INKS, HEAT OR RADIATION CURABLE COATINGS | UNION CARBIDE CORPORATION (US) | 1978-10-10 | — | — | US | disclosed |
| US-4112017-A | UNSATURATED ADDITION POLYMERIZABLE URETHANE RESINS | LORD CORPORATION (US) | 1978-09-05 | — | — | US | disclosed |
| US-4100046-A | Radiation polymerizable cycloalkenyl derivatives of acrylated epoxidized fatty oils or fatty acids | UNION CARBIDE CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
| US-4066582-A | IMPROVED ACRYLATE BASED RADIATION CURABLE COATING COMPOSITIONS CONTAINING NITROCELLULOSE | UNION CARBIDE CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-3996394-A | PHOTOPOLYMERIZATION | UNION CARBIDE CORPORATION (US) | 1976-12-07 | — | — | US | disclosed |
| US-3966572-A | Photocurable low gloss coatings containing silica and acrylic acid | UNION CARBIDE CORPORATION (US) | 1976-06-29 | — | — | US | disclosed |
| US-3943103-A | CONTAI | UNION CARBIDE CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200376131-A1 | Pegylated Carfilzomib Compounds | FCGRT, EPOR, MCL1 | KMT2A 746/4885CFD 2561/4885ALDH1A1 1647/4885 |
| US-11077198-B2 | Pegylated carfilzomib compounds | FCGRT, EPOR, MCL1 | KMT2A 746/4885CFD 2561/4885ALDH1A1 1647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.